The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point of Care Infectious Disease Testing-Global Market Insights and Sales Trends 2025
Synopsis
Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.
The global Point of Care Infectious Disease Testing market size is expected to reach US$ 4411.8 million by 2029, growing at a CAGR of 7.7% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Others, are propelling Point of Care Infectious Disease Testing market. HIV POC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the HBV POC segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Infectious Disease Testing covered in this report include Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health and Quest Diagnostics, etc.
The global Point of Care Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alere
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens Healthineers
BD
Chembio Diagnostics
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Labs
bioMérieux
Sight Diagnostics
Gene POC
Trivitron Healthcare
OJ-Bio
Ortho-Clinical Diagnostics
Global Point of Care Infectious Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Infectious Disease Testing market, Segment by Type:
HIV POC
HBV POC
Pneumonia or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza POC
Others
Global Point of Care Infectious Disease Testing market, by Application
Hospitals
Clinics
Home
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.
The global Point of Care Infectious Disease Testing market size is expected to reach US$ 4411.8 million by 2029, growing at a CAGR of 7.7% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Others, are propelling Point of Care Infectious Disease Testing market. HIV POC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the HBV POC segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Infectious Disease Testing covered in this report include Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health and Quest Diagnostics, etc.
The global Point of Care Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alere
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens Healthineers
BD
Chembio Diagnostics
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Labs
bioMérieux
Sight Diagnostics
Gene POC
Trivitron Healthcare
OJ-Bio
Ortho-Clinical Diagnostics
Global Point of Care Infectious Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Infectious Disease Testing market, Segment by Type:
HIV POC
HBV POC
Pneumonia or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza POC
Others
Global Point of Care Infectious Disease Testing market, by Application
Hospitals
Clinics
Home
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point of Care Infectious Disease Testing
1.1 Point of Care Infectious Disease Testing Market Overview
1.1.1 Point of Care Infectious Disease Testing Product Scope
1.1.2 Point of Care Infectious Disease Testing Market Status and Outlook
1.2 Global Point of Care Infectious Disease Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point of Care Infectious Disease Testing Market Size by Region (2018-2029)
1.4 Global Point of Care Infectious Disease Testing Historic Market Size by Region (2018-2023)
1.5 Global Point of Care Infectious Disease Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point of Care Infectious Disease Testing Market Size (2018-2029)
1.6.1 North America Point of Care Infectious Disease Testing Market Size (2018-2029)
1.6.2 Europe Point of Care Infectious Disease Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Point of Care Infectious Disease Testing Market Size (2018-2029)
1.6.4 Latin America Point of Care Infectious Disease Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Point of Care Infectious Disease Testing Market Size (2018-2029)
2 Point of Care Infectious Disease Testing Market by Type
2.1 Introduction
2.1.1 HIV POC
2.1.2 HBV POC
2.1.3 Pneumonia or Streptococcus Associated Infections
2.1.4 Respiratory Syncytial Virus (RSV) POC
2.1.5 HPV POC
2.1.6 Influenza POC
2.1.7 Others
2.2 Global Point of Care Infectious Disease Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point of Care Infectious Disease Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point of Care Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point of Care Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point of Care Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point of Care Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point of Care Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
3 Point of Care Infectious Disease Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Home
3.1.4 Others
3.2 Global Point of Care Infectious Disease Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point of Care Infectious Disease Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point of Care Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point of Care Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point of Care Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point of Care Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point of Care Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
4 Point of Care Infectious Disease Testing Competition Analysis by Players
4.1 Global Point of Care Infectious Disease Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2022)
4.3 Date of Key Players Enter into Point of Care Infectious Disease Testing Market
4.4 Global Top Players Point of Care Infectious Disease Testing Headquarters and Area Served
4.5 Key Players Point of Care Infectious Disease Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Point of Care Infectious Disease Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alere
5.1.1 Alere Profile
5.1.2 Alere Main Business
5.1.3 Alere Point of Care Infectious Disease Testing Products, Services and Solutions
5.1.4 Alere Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Alere Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 F. Hoffmann-La Roche
5.3.1 F. Hoffmann-La Roche Profile
5.3.2 F. Hoffmann-La Roche Main Business
5.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthineers Recent Developments
5.4 Siemens Healthineers
5.4.1 Siemens Healthineers Profile
5.4.2 Siemens Healthineers Main Business
5.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Products, Services and Solutions
5.4.4 Siemens Healthineers Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthineers Recent Developments
5.5 BD
5.5.1 BD Profile
5.5.2 BD Main Business
5.5.3 BD Point of Care Infectious Disease Testing Products, Services and Solutions
5.5.4 BD Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.5.5 BD Recent Developments
5.6 Chembio Diagnostics
5.6.1 Chembio Diagnostics Profile
5.6.2 Chembio Diagnostics Main Business
5.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Products, Services and Solutions
5.6.4 Chembio Diagnostics Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Chembio Diagnostics Recent Developments
5.7 Trinity Biotech
5.7.1 Trinity Biotech Profile
5.7.2 Trinity Biotech Main Business
5.7.3 Trinity Biotech Point of Care Infectious Disease Testing Products, Services and Solutions
5.7.4 Trinity Biotech Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Trinity Biotech Recent Developments
5.8 Cardinal Health
5.8.1 Cardinal Health Profile
5.8.2 Cardinal Health Main Business
5.8.3 Cardinal Health Point of Care Infectious Disease Testing Products, Services and Solutions
5.8.4 Cardinal Health Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Cardinal Health Recent Developments
5.9 Quest Diagnostics
5.9.1 Quest Diagnostics Profile
5.9.2 Quest Diagnostics Main Business
5.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Products, Services and Solutions
5.9.4 Quest Diagnostics Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Quest Diagnostics Recent Developments
5.10 Bio-Rad Labs
5.10.1 Bio-Rad Labs Profile
5.10.2 Bio-Rad Labs Main Business
5.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Products, Services and Solutions
5.10.4 Bio-Rad Labs Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Labs Recent Developments
5.11 bioMérieux
5.11.1 bioMérieux Profile
5.11.2 bioMérieux Main Business
5.11.3 bioMérieux Point of Care Infectious Disease Testing Products, Services and Solutions
5.11.4 bioMérieux Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.11.5 bioMérieux Recent Developments
5.12 Sight Diagnostics
5.12.1 Sight Diagnostics Profile
5.12.2 Sight Diagnostics Main Business
5.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Products, Services and Solutions
5.12.4 Sight Diagnostics Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Sight Diagnostics Recent Developments
5.13 Gene POC
5.13.1 Gene POC Profile
5.13.2 Gene POC Main Business
5.13.3 Gene POC Point of Care Infectious Disease Testing Products, Services and Solutions
5.13.4 Gene POC Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Gene POC Recent Developments
5.14 Trivitron Healthcare
5.14.1 Trivitron Healthcare Profile
5.14.2 Trivitron Healthcare Main Business
5.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Products, Services and Solutions
5.14.4 Trivitron Healthcare Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Trivitron Healthcare Recent Developments
5.15 OJ-Bio
5.15.1 OJ-Bio Profile
5.15.2 OJ-Bio Main Business
5.15.3 OJ-Bio Point of Care Infectious Disease Testing Products, Services and Solutions
5.15.4 OJ-Bio Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.15.5 OJ-Bio Recent Developments
5.16 Ortho-Clinical Diagnostics
5.16.1 Ortho-Clinical Diagnostics Profile
5.16.2 Ortho-Clinical Diagnostics Main Business
5.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Products, Services and Solutions
5.16.4 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Ortho-Clinical Diagnostics Recent Developments
6 North America
6.1 North America Point of Care Infectious Disease Testing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Point of Care Infectious Disease Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point of Care Infectious Disease Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point of Care Infectious Disease Testing Market Dynamics
11.1 Point of Care Infectious Disease Testing Industry Trends
11.2 Point of Care Infectious Disease Testing Market Drivers
11.3 Point of Care Infectious Disease Testing Market Challenges
11.4 Point of Care Infectious Disease Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
